How do you approach a stage IIIC triple positive IDC, s/p neoadjuvant TCH and P, lumpectomy, and ALND with significant residual disease at the time of surgery?  

Would you recommend additional cytotoxic chemotherapy and/or switch her anti-Her therapy to T-DM1?



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Florida Cancer Specialists and Research Institute
@Debu Tripathy, Could you please explain this conc...
Medical Oncologist at University of Iowa Holden Comprehensive Cancer Center
I believe this uncertainty is related to the fact ...
Sign in or Register to read more

Answer from: Medical Oncologist at Academic Institution

Answer from: Medical Oncologist at Community Practice

Answer from: Medical Oncologist at Community Practice

Answer from: Medical Oncologist at Community Practice
Comments
Medical Oncologist at University of Kentucky Medical Center
I will do kadcyla. 
Sign in or Register to read more